Damon Runyon Cancer Research Foundation

This research was published in Nature.

The prestigious, four-year fellowship encourages the nation’s most promising young scientists to pursue careers in cancer research.

Eventually, artificial intelligence could be used to guide treatment decision-making.

These five pediatric cancer research fellows will receive funding for four years for their innovative project.

This research was published in Nature.

The key to longer survival, it turned out, was the presence of specific immune cells, known as CD8+ T cells, within the tumor tissue.

Anyone looking to familiarize themselves with Damon Runyon’s distinctive style need look no further.

The one-year intensive cancer research internship program is for students who come from backgrounds underrepresented in the sciences.

This research was published in Cell.

A Damon Runyon scientist investigates the role of aneuploidy, or abnormal chromosome number, in cancer—and in possible treatments.

The next step will be to test if this tumor-killing circuit can be activated against human glioblastoma cells.

The 2024 Timmerman Traverse aims to raise at least $1 million for Damon Runyon’s cancer research. [VIDEO]

Balachandran’s work could “transform the treatment of pancreatic cancer…and provide proof of concept for future cancer vaccines.”

Runners and walkers ranging in age from 5 to 87 traversed the course at Yankee Stadium alongside scientists funded by Damon Runyon.

Researchers unveil a less toxic, more efficient method to genetically engineer immune cells that target tumor cells.

Because of its rarity, adenoid cystic carcinoma has received relatively little attention from cancer researchers.

The results were extraordinary, with participants experiencing an average 90% reduction in tumor size.